HELIOS-A: IMPACT OF VUTRISIRAN ON QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS

被引:0
|
作者
Ajroud-Driss, Senda [1 ]
Berk, John L. [2 ]
Adams, David [3 ,4 ]
Gillmore, Julian [5 ]
Lin, Kon-Ping [6 ]
Kale, Parag [7 ]
Koike, Haruki [8 ]
Aldinc, Emre [9 ]
Chen, Chongshu [9 ]
Vest, John [9 ]
Obici, Laura [10 ]
机构
[1] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Neurol, Chicago, IL 60611 USA
[2] Boston Med Ctr, Boston, MA USA
[3] Univ Paris Saclay, INSERM, U1195, Le Kremlin Bicetre, France
[4] CHU Bicetre, AP HP, Neurol Dept, Le Kremlin Bicetre, France
[5] UCL, Royal Free Hosp, Natl Amyloidosis Ctr, London, England
[6] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan
[7] Baylor Univ, Med Ctr, Dallas, TX USA
[8] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi, Japan
[9] Alnylam Pharmaceut, Cambridge, MA USA
[10] IRCCS Fdn Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
引用
收藏
页码:S40 / S41
页数:2
相关论文
共 50 条
  • [31] Cardiovascular burden prior to diagnosis of hereditary transthyretin-mediated amyloidosis
    Llonch, M. V.
    Ortiz-Perez, J. T.
    Reddy, S. R.
    Chang, E.
    Tarbox, M. H. Marian
    Pollock, M. R.
    Nativi-Nicolau, J.
    Fine, N. M.
    EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 : 173 - 174
  • [32] Impact of Patisiran, an RNAi Therapeutic, on Diarrhea Symptoms in Patients With Hereditary Transthyretin-Mediated Amyloidosis
    Obici, Laura
    Gonzalez-Duarte, Alejandra
    Waddington-Cruz, Marcia
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Ueda, Mitsuharu
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S1657 - S1657
  • [33] Patisiran, an RNAi therapeutic for the treatment of hereditary transthyretin-mediated amyloidosis
    Kristen, Arnt, V
    Ajroud-Driss, Senda
    Conceicao, Isabel
    Gorevic, Peter
    Kyriakides, Theodoros
    Obici, Laura
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2019, 9 (01) : 5 - 24
  • [34] Impact of Patisiran, an RNAi Therapeutic, on Orthostatic Intolerance in Patients with Hereditary Transthyretin-Mediated Amyloidosis
    Judge, Daniel P.
    Gonzalez-Duarte, Alejandra
    Dispenzieri, Angela
    Lin, Hollis
    Merkel, Madeline
    Wang, Yue
    Polydefkis, Michael
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S78 - S78
  • [35] Hereditary transthyretin-mediated amyloidosis masquerading as diabetic neuropathy and lumbar radiculopathy
    Horiuchi, Kohei
    Hortelano, Chiara
    Nikfar, Reza
    Fogel, Joyce
    BMJ CASE REPORTS, 2024, 17 (09)
  • [36] Alnylam Act®: Heterogenous Disease Manifestations of Hereditary Transthyretin-Mediated Amyloidosis
    Malladi, Ruthvik
    Truty, Rebecca
    Winder, Tom
    Dinh, Quinn
    Melanson, Maria
    Agarwal, Sonalee
    JOURNAL OF CARDIAC FAILURE, 2019, 25 (08) : S111 - S112
  • [37] Inotersen for the treatment of adults with polyneuropathy caused by hereditary transthyretin-mediated amyloidosis
    Gertz, Morie A.
    Scheinberg, Morton
    Waddington-Cruz, Marcia
    Heitner, Stephen B.
    Karam, Chafic
    Drachman, Brian
    Khella, Sami
    Whelan, Carol
    Obici, Laura
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 701 - 711
  • [38] Hope on the horizon: FDA approves eplontersen for hereditary transthyretin-mediated amyloidosis
    Anwar, Insa Binte
    Ahmed, Iqra Furqan
    Mahmood, Fariha
    Haseeb, Abdul
    Ahmed, Khabab Abbasher Hussien Mohamed
    ANNALS OF MEDICINE AND SURGERY, 2025, 87 (01): : 20 - 23
  • [39] Quality of life outcomes in APOLLO, the phase 3 trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis
    Obici, Laura
    Berk, John L.
    Gonzalez-Duarte, Alejandra
    Coelho, Teresa
    Gillmore, Julian
    Schmidt, Hartmut H. -J.
    Schilling, Matthias
    Yamashita, Taro
    Labeyrie, Celine
    Brannagan, Thomas H., III
    Ajroud-Driss, Senda
    Gorevic, Peter
    Kristen, Arnt V.
    Franklin, Jaclyn
    Chen, Jihong
    Sweetser, Marianne T.
    Wang, Jing Jing
    Adams, David
    AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2020, 27 (03): : 153 - 162
  • [40] Hereditary Transthyretin-mediated Amyloidosis Masquerading as Diabetic Neuropathy and Lumbar Radiculopathy
    Horiuchi, K.
    Hortelano, C.
    Fogel, J.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2024, 72 : S187 - S187